Keyphrases
Point mutation
100%
Lung Cancer
100%
Complementary DNA (cDNA)
100%
P53 Gene
100%
Tumor DNA
66%
Genomic DNA (gDNA)
66%
Polymorphism
66%
Lung Tumor
66%
Cell-to-cell
33%
Loss of Heterozygosity
33%
DNA Sequencing
33%
Inherited Disorders
33%
Direct Sequencing
33%
Alpha-1 Antitrypsin Deficiency
33%
Non-small Cell Lung Cancer (NSCLC)
33%
Sequence Analysis
33%
Cystic Fibrosis
33%
Oncogene
33%
Pulmonary Disease
33%
Target Size
33%
Tumor Genomics
33%
Base Change
33%
Small Cell
33%
Single-point mutation
33%
Additional mutations
33%
Rapid Analysis
33%
Single Base
33%
RNase Protection
33%
Denaturing Gradient Gel Electrophoresis
33%
Efficient Analysis
33%
Codon 72
33%
Heminested PCR
33%
Biochemistry, Genetics and Molecular Biology
P53
100%
Point Mutation
100%
Protein P53
100%
Genomics
100%
DNA Sequence
66%
Intron
66%
Loss of Heterozygosity
33%
Protein Sequencing
33%
Cystic Fibrosis
33%
Oncogene
33%
Codon
33%
Alpha 1-Antitrypsin
33%
Ribonuclease
33%
Shotgun Sequencing
33%
Nested Polymerase Chain Reaction
33%
Gel Electrophoresis
33%